{"nctId":"NCT00784225","briefTitle":"S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000","startDateStruct":{"date":"2004-07"},"conditions":["Cataract","Macular Degeneration"],"count":13475,"armGroups":[{"label":"Vitamin E + selenium placebo","type":"EXPERIMENTAL","interventionNames":["Drug: vitamin E","Drug: selenium placebo"]},{"label":"Selenium + vitamin E placebo","type":"EXPERIMENTAL","interventionNames":["Drug: selenium","Drug: vitamin E placebo","Drug: selenium placebo"]},{"label":"Vitamin E + selenium","type":"EXPERIMENTAL","interventionNames":["Drug: selenium","Drug: vitamin E"]},{"label":"Vitamin E placebo + selenium placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: vitamin E placebo","Drug: selenium placebo"]}],"interventions":[{"name":"selenium","otherNames":["L-selenomethionine"]},{"name":"vitamin E","otherNames":["alpha tocopherol"]},{"name":"vitamin E placebo","otherNames":["placebo"]},{"name":"selenium placebo","otherNames":["placebo"]}],"eligibilityModule":{"eligibilityCriteria":"DISEASE CHARACTERISTICS:\n\n* Enrolled on the Selenium and Vitamin E Prostate Cancer Prevention Trial (SELECT) SWOG-S0000\n* Diagnosis of 1 of the following:\n\n  * Age-related macular degeneration (AMD) at baseline or at follow-up\n  * Cataract or a cataract extraction at follow-up (Closed for accrual as of 10/01/29)\n\n    * Participants with a prior diagnosis of cataract at baseline followed by another cataract event (cataract diagnosis or a cataract extraction) at follow-up are not eligible\n    * Participants with a prior diagnosis of cataract at baseline followed by a diagnosis of AMD at follow-up are eligible\n\nPATIENT CHARACTERISTICS:\n\n* See Disease Characteristics\n\nPRIOR CONCURRENT THERAPY:\n\n* Not applicable","healthyVolunteers":true,"sex":"MALE","minimumAge":"50 Years","maximumAge":"120 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Visually Significant Age-related Macular Degeneration (AMD)","description":"Visually significant age-related AMD was defined as incident AMD responsible for reduction in best corrected visual acuity to 20/30 or worse(AMD 20/30)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"12","spread":null},{"groupId":"OG002","value":"9","spread":null},{"groupId":"OG003","value":"12","spread":null}]},{"measurements":[{"groupId":"OG000","value":"6681","spread":null},{"groupId":"OG001","value":"6687","spread":null},{"groupId":"OG002","value":"6677","spread":null},{"groupId":"OG003","value":"6691","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Cataract and Best Corrected Visual-acuity of 20/30","description":"Incident cataract was defined as lens opacity diagnosed after randomization but prior to end of study, age-related in origin, and best-corrected visual acuity of 20/30 or worse attributable to the opacity.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"185","spread":null},{"groupId":"OG001","value":"204","spread":null},{"groupId":"OG002","value":"197","spread":null},{"groupId":"OG003","value":"192","spread":null}]},{"measurements":[{"groupId":"OG000","value":"5409","spread":null},{"groupId":"OG001","value":"5469","spread":null},{"groupId":"OG002","value":"5436","spread":null},{"groupId":"OG003","value":"5442","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Advanced AMD","description":"Advanced AMD was defined as the occurrence of disciform scars, or geographic atrophy or retinal pigment epithelium (RPE) detachment in either or both eyes at AMD diagnosis.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"4","spread":null},{"groupId":"OG002","value":"7","spread":null},{"groupId":"OG003","value":"7","spread":null}]},{"measurements":[{"groupId":"OG000","value":"6680","spread":null},{"groupId":"OG001","value":"6695","spread":null},{"groupId":"OG002","value":"6679","spread":null},{"groupId":"OG003","value":"6696","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Underwent Cataract Extraction","description":"Cataract extraction was defined as the surgical removal of an incident cataract.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"99","spread":null},{"groupId":"OG001","value":"120","spread":null},{"groupId":"OG002","value":"114","spread":null},{"groupId":"OG003","value":"105","spread":null}]},{"measurements":[{"groupId":"OG000","value":"5495","spread":null},{"groupId":"OG001","value":"5553","spread":null},{"groupId":"OG002","value":"5519","spread":null},{"groupId":"OG003","value":"5529","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":44,"n":3374},"commonTop":["Cardiac ischemia/infarction"]}}}